Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,121.02
(
0.44%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.65
(
2.39%
)
Bitcoin
74,322.77
(
-0.70%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 86124

Wednesday, 11/11/2009 12:55:00 PM

Wednesday, November 11, 2009 12:55:00 PM

Post# of 257253

[After each report, Merck said doctors shouldn’t change treatment based on the results and urged them to wait for data from a larger trial to be completed in 2012.

This larger one is the IMPROVE-IT trial (Vytorin vs. Simvastatin) and should Zetia disappoint in ARBITER 6, outcome for Vytorin in the IMPROVE-IT trial looks shady.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today